Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2021 16:01 ET | Source: CareDx, Inc.

CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance

SOUTH SAN FRANCISCO, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
October 21, 2021 07:00 ET | Source: CareDx, Inc.

CareDx’s AlloSure Demonstrates Better Accuracy Than Current Standards of Care in Independent Kidney Transplant Study

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of...
October 19, 2021 07:00 ET | Source: CareDx, Inc.

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

SOUTH SAN FRANCISCO, Calif. and IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and...
October 14, 2021 16:01 ET | Source: CareDx, Inc.

CareDx to Report Third Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
October 12, 2021 10:18 ET | Source: CareDx, Inc.

AlloSure, the First dd-cfDNA in Heart and Kidney Transplantation, Launches for Lung Transplant Patients

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
September 30, 2021 16:01 ET | Source: CareDx, Inc.

CareDx Extends Leadership in Multimodality Transplant Care with KidneyCare Validation Publication

SOUTH SAN FRANCISCO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – a leading precision medicine company focused on the discovery, development, and commercialization of...
September 28, 2021 19:18 ET | Source: CareDx, Inc.

CareDx Continues to Fight for Innovation in Transplantation

False Advertising Lawsuit Against Natera is Set to Go to Trial CareDx Plans to Appeal Recent Ruling in Patent Case SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc....
September 27, 2021 07:00 ET | Source: CareDx, Inc.

CareDx Presents Latest Data on AlloSeq Portfolio at ASHI 2021

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
September 15, 2021 08:00 ET | Source: CareDx, Inc.

CareDx Names Longtime Patient Advocate Art Torres to Board of Directors

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
September 02, 2021 07:00 ET | Source: CareDx, Inc.

CareDx to Participate in Upcoming Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...